The U.S. FDA has cleared Artrya Ltd.’s 510 (k) for its Salix Coronary Plaque (SCP) module that is a bolt-on module to the company’s Salix coronary anatomy platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback